Avalo Therapeutics Inc (AVTX) — Working Capital to Net Assets Ratio
Avalo Therapeutics Inc (AVTX) has a Working Capital to Net Assets ratio of 115.6% as of September 2025. Working capital of $105.87 Million (current assets of $113.85 Million minus current liabilities of $7.97 Million) is measured against net assets of $91.55 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see AVTX total asset value.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Avalo Therapeutics Inc Working Capital to Net Assets (2012–2024)
This chart shows how Avalo Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 115.6%, reflecting working capital of $105.87 Million against net assets of $91.55 Million USD. Explore Avalo Therapeutics Inc capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Avalo Therapeutics Inc (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Avalo Therapeutics Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read AVTX liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 99.2% | $131.93 Million | $133.03 Million | $138.89 Million | $6.96 Million | ▲ +47.5 pp |
| 2023 | 51.7% | $3.78 Million | $7.30 Million | $8.39 Million | $4.62 Million | ▼ -0.5 pp |
| 2022 | 52.2% | $-5.70 Million | $-10.91 Million | $16.42 Million | $22.11 Million | ▼ -129.6 pp |
| 2021 | 181.8% | $41.96 Million | $23.08 Million | $61.84 Million | $19.89 Million | ▲ +137.9 pp |
| 2020 | 43.9% | $10.78 Million | $24.56 Million | $26.00 Million | $15.22 Million | ▲ +17.4 pp |
| 2019 | 26.5% | $5.56 Million | $21.00 Million | $17.72 Million | $12.16 Million | ▲ +47.0 pp |
| 2018 | -20.5% | $-4.28 Million | $20.91 Million | $21.93 Million | $26.22 Million | ▼ -19.0 pp |
| 2017 | -1.5% | $-415.07K | $27.86 Million | $10.99 Million | $11.41 Million | ▼ -654.1 pp |
| 2016 | 652.7% | $1.35 Million | $207.00K | $5.66 Million | $4.31 Million | ▲ +532.1 pp |
| 2015 | 120.6% | $15.77 Million | $13.08 Million | $21.62 Million | $5.85 Million | ▲ +147.8 pp |
| 2014 | -27.2% | $7.17 Million | $-26.33 Million | $12.16 Million | $4.99 Million | ▼ -21.2 pp |
| 2013 | -6.0% | $1.07 Million | $-17.85 Million | $4.14 Million | $3.07 Million | ▼ -105.2 pp |
| 2012 | 99.2% | $8.41 Million | $8.48 Million | $9.95 Million | $1.54 Million | — |